On June 28, 2022, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) discussed whether there would need to be a change to the current vaccine strain composition in the current COVID-19 vaccines. After discussing, the committee did vote in favor to include an Omicron BA.4/5 component in COVID-19 vaccines that would be used for boosters beginning in fall 2022. See the FDA media statement: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses for further details.
In accordance with the recent recommendations, MIIC now forecasts a first dose of Spikevax-MOD and Comirnaty-PFR for people ages 6 months and older. Other changes in the forecaster include a first booster dose for anyone ages 5 years and older and a second booster dose of a mRNA COVID-19 vaccine four months after the date of the second dose for people ages 50 years and older. If you have questions regarding the forecaster in MIIC, please contact the MIIC help desk at health.miichelp@state.mn.us.
On July 12 from 11:00 a.m. to 12:00 p.m. the National Association of Community Health Centers (NACHC) will be hosting a webinar titled: We Can Do This: Educating Nurses and Pediatric Staff About new COVID-19 Vaccines for Children.
Wanda Montalvo, PhD, RN, FAAN, a senior fellow and team lead for public health integration and innovation at NACHC, will talk with pediatrician Lisa Costello, MD, MPH, about vaccine benefits, administration, and availability, as well as answer some commonly asked questions. Erin Hemlin, MA, partnerships lead for the U.S. Department of Health and Human Services’ COVID-19 Public Education Campaign, We Can Do This, will share new provider and patient education materials on pediatric COVID-19 vaccines that the Campaign has developed.
Register at National Association Of Community Health Centers WebEx Enterprise Site
|